CLASS II ONGOING Device recall · Reported 29 Mar 2023 · FDA Enforcement Report

Attune Revision Limb Preservation System (LPS) Tibial Insert XSM recalled

DePuy Orthopaedics is recalling Attune Revision Limb Preservation System (LPS) Tibial Insert XSM, distributed nationwide in the US. The recall was initiated on 15 Feb 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesGTIN: 10603295491033; Lot: JP9022
Quantity recalled7 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1265-2023
FDA event ID
91752
Recalling firm
DePuy Orthopaedics, Warsaw, IN
Classification
Class II
Status
Ongoing
Recall initiated
15 Feb 2023
FDA classified
17 Mar 2023
Reported
29 Mar 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

15 Feb 2023Recall initiated by company
17 Mar 2023Classified by FDA+30 days
29 Mar 2023Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The subject product lots are being recalled because they received a higher than specified irradiation dose. This exceeds the validated range for exposure to gamma radiation of these devices and may result in changes to the implant material properties.

Product as listed by the FDA

Attune Revision Limb Preservation System (LPS) Tibial Insert XSM 26MM, Part Number 151760226

Where it was distributed

Worldwide distribution - US Nationwide and the countries of Canada, Poland, Germany, India, Australia, & New Zealand

Nationwide

Questions about this recall

Is Attune Revision Limb Preservation System (LPS) Tibial Insert XSM recalled?

Yes. DePuy Orthopaedics recalled Attune Revision Limb Preservation System (LPS) Tibial Insert XSM on 15 Feb 2023. The recall is Class II and its status is Ongoing. Recall number Z-1265-2023.

Why was it recalled?

The subject product lots are being recalled because they received a higher than specified irradiation dose. This exceeds the validated range for exposure to gamma radiation of these devices and may result in changes to the implant material properties.

Which lots are affected?

GTIN: 10603295491033; Lot: JP9022

Where was it sold?

Worldwide distribution - US Nationwide and the countries of Canada, Poland, Germany, India, Australia, & New Zealand

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from DePuy Orthopaedics

All 153

Other Hip & Knee Implants recalls

All 3,097